Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

18,180 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeting prostaglandin E EP receptors to inhibit metastasis.
Fulton AM, Ma X, Kundu N. Fulton AM, et al. Cancer Res. 2006 Oct 15;66(20):9794-7. doi: 10.1158/0008-5472.CAN-06-2067. Cancer Res. 2006. PMID: 17047037 Review.
Promoter methylation regulates cyclooxygenase expression in breast cancer.
Ma X, Yang Q, Wilson KT, Kundu N, Meltzer SJ, Fulton AM. Ma X, et al. Breast Cancer Res. 2004;6(4):R316-21. doi: 10.1186/bcr793. Epub 2004 Apr 26. Breast Cancer Res. 2004. PMID: 15217498 Free PMC article.
Cyclooxygenase inhibitors modulate NK activities that control metastatic disease.
Kundu N, Walser TC, Ma X, Fulton AM. Kundu N, et al. Cancer Immunol Immunother. 2005 Oct;54(10):981-7. doi: 10.1007/s00262-005-0669-2. Epub 2005 May 13. Cancer Immunol Immunother. 2005. PMID: 15891886
Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis.
Ma X, Kundu N, Rifat S, Walser T, Fulton AM. Ma X, et al. Cancer Res. 2006 Mar 15;66(6):2923-7. doi: 10.1158/0008-5472.CAN-05-4348. Cancer Res. 2006. PMID: 16540639
Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.
Walser TC, Rifat S, Ma X, Kundu N, Ward C, Goloubeva O, Johnson MG, Medina JC, Collins TL, Fulton AM. Walser TC, et al. Cancer Res. 2006 Aug 1;66(15):7701-7. doi: 10.1158/0008-5472.CAN-06-0709. Cancer Res. 2006. PMID: 16885372
Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function.
Kundu N, Ma X, Holt D, Goloubeva O, Ostrand-Rosenberg S, Fulton AM. Kundu N, et al. Breast Cancer Res Treat. 2009 Sep;117(2):235-42. doi: 10.1007/s10549-008-0180-5. Epub 2008 Sep 16. Breast Cancer Res Treat. 2009. PMID: 18792778 Free PMC article.
CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model.
Ma X, Norsworthy K, Kundu N, Rodgers WH, Gimotty PA, Goloubeva O, Lipsky M, Li Y, Holt D, Fulton A. Ma X, et al. Mol Cancer Ther. 2009 Mar;8(3):490-8. doi: 10.1158/1535-7163.MCT-08-0485. Epub 2009 Mar 10. Mol Cancer Ther. 2009. PMID: 19276169
Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities.
Ma X, Kundu N, Ioffe OB, Goloubeva O, Konger R, Baquet C, Gimotty P, Reader J, Fulton AM. Ma X, et al. Mol Cancer Res. 2010 Oct;8(10):1310-8. doi: 10.1158/1541-7786.MCR-10-0003. Epub 2010 Sep 21. Mol Cancer Res. 2010. PMID: 20858737 Free PMC article.
18,180 results
Jump to page
Feedback